Home Cart Sign in  
Chemical Structure| 283173-50-2 Chemical Structure| 283173-50-2
Chemical Structure| 283173-50-2

Rucaparib

CAS No.: 283173-50-2

Rucaparib is an inhibitor ofPARP with Ki of 1.4 nM for PARP1, also showing binding affinity to eight otherPARP domains.

Synonyms: AG014699; PF-01367338; AG-014447

4.5 *For Research Use Only !

Cat. No.: A115210 Purity: 98%

Change View

Size Price

US Stock

Global Stock

In Stock
1mg łÇʶÊÊ Inquiry Inquiry
5mg łÇ§¶ÊÊ Inquiry Inquiry
10mg łÇò¶ÊÊ Inquiry Inquiry
25mg łË§¶ÊÊ Inquiry Inquiry
100mg łÍ˶ÊÊ Inquiry Inquiry
250mg łòó¶ÊÊ Inquiry Inquiry
1g łÇďò¶ÊÊ Inquiry Inquiry
5g łòÇÿ¶ÊÊ Inquiry Inquiry

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1mg

    łÇʶÊÊ

  • 5mg

    łÇ§¶ÊÊ

  • 10mg

    łÇò¶ÊÊ

  • 25mg

    łË§¶ÊÊ

  • 100mg

    łÍ˶ÊÊ

  • 250mg

    łòó¶ÊÊ

  • 1g

    łÇďò¶ÊÊ

  • 5g

    łòÇÿ¶ÊÊ

In Stock

- +

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support Online Technical Q&A
Product Citations

Product Citations

Beckers, Igor ; O'Rourke, Galahad ; De Vos, Dirk ;

Abstract: The C-H arylation of indoles holds the promise to shorten synthetic routes in the production of pharmaceuticals. However, late-stage C-H activation reactions often rely on the presence of protecting groups or stoichiometric metal additives. The regiospecific C-H arylation of a highly functionalized azepino[5,3,4-cd]indole scaffold lacking directing groups via Pd(II) and Cu(II) co-catalysis is reported. The direct C-H coupling was demonstrated in the convergent synthesis of rucaparib, an FDA approved anticancer drug.

Keywords: C-H activation ; indole ; arylation ; homogeneous catalysis ; palladium ; copper ; organic synthesis ; pharmaceuticals

Purchased from AmBeed: ;

Alternative Products

Product Details of Rucaparib

CAS No. :283173-50-2
Formula : C19H18FN3O
M.W : 323.36
SMILES Code : O=C1NCCC2=C(C3=CC=C(CNC)C=C3)NC4=C2C1=CC(F)=C4
Synonyms :
AG014699; PF-01367338; AG-014447
MDL No. :MFCD11977252
InChI Key :HMABYWSNWIZPAG-UHFFFAOYSA-N
Pubchem ID :9931954

Safety of Rucaparib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Rucaparib

epigenetics
DNA

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description Reference
HepG2 cells 5, 10, 20, 40, 80 μM 24, 48, 72, 96 h AG014699 inhibited the proliferation of HepG2 cells in a time- and concentration-dependent manner. PMC5482153

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03533946 Prostate Cancer PHASE2 TERMINATED 2023-01-12 Huntsman Cancer Institute, Sal... More >>t Lake City, Utah, 84112, United States Less <<
NCT03911453 Breast Cancer EARLY_PHASE1 COMPLETED 2021-07-16 University of Arizona Cancer C... More >>enter, Tucson, Arizona, 85724, United States Less <<
NCT03413995 Prostate Cancer Metastatic PHASE2 COMPLETED 2024-09-12 Johns Hopkins Hospital, Baltim... More >>ore, Maryland, 21205, United States|Weill Cornell Medical College, New York, New York, 10065, United States Less <<
NCT02042378 Pancreatic Cancer|Pancreatic D... More >>uctal Adenocarcinoma Less << PHASE2 COMPLETED 2025-05-16 Cedars Sinai Medical Center, L... More >>os Angeles, California, 90048, United States|Mayo Clinic, Rochester, Minnesota, 55902, United States|New York University, New York, New York, 10012, United States|University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States|MD Anderson Cancer Center, Houston, Texas, 77030, United States|Rambam Healthcare Campus, Haifa, 31096, Israel|Hadassah Hebrew University Hospital (Sharett Institute of Oncology), Jerusalem, 91120, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv, 64239, Israel Less <<
NCT01482715 Ovarian Cancer|Fallopian Tube ... More >>Cancer|Peritoneal Cancer|Advanced Solid Tumor With Evidence of Germline or Somatic BRCA Less << PHASE1|PHASE2 COMPLETED 2025-05-19 UCSF, San Francisco, Californi... More >>a, 94155, United States|Sarah Cannon Research Institute, Sarasota, Florida, 34232, United States|Dana-Farber Cancer Institute (Part 3 only), Boston, Massachusetts, 02215, United States|Karmanos Cancer Institute, Detroit, Michigan, 48201, United States|University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States|Sarah Cannon Research Institute, Nashville, Tennessee, 37203, United States|Princess Margaret Cancer Centre, Toronto, Ontario, MSG 2M9, Canada|Sheba Medical Center, Ramat Gan, 52621, Israel|Tel Aviv Sourasky Medical Center, Tel Aviv, 632394, Israel|Hospital Vall d'Hebron, Barcelona, 8035, Spain|Guy's and St Thomas NHS Foundation Trust, London, England, SE1 9RT, United Kingdom|Royal Marsden NHS Foundation Trust, London, England, SW3 6JJ, United Kingdom|Imperial College Healthcare, London, England, W12 0HS, United Kingdom|Newcastle University, Newcastle Upon Tyne, England, UK NE7, United Kingdom|Institution of Cancer Science, University of Glasgow Wolfson Wohl Cancer Research, Glasgow, Scotland, G61 1QH, United Kingdom|University College London Cancer Institute, London, WC1E 6BT, United Kingdom Less <<
NCT03397394 Bladder Cancer|Urothelial Carc... More >>inoma|Metastatic Urothelial Carcinoma|Renal Pelvis Carcinoma|Ureter Carcinoma|Urinary Bladder Carcinoma|Urethra Carcinoma|Muscle Invasive Bladder Cancer Less << PHASE2 TERMINATED 2020-01-15 Pinnacle Oncology, Honor Healt... More >>h, Scottsdale, Arizona, 85258, United States|University of California San Diego (UCSD), Moores Cancer Center, La Jolla, California, 92093, United States|University of California, Los Angeles (UCLA), Los Angeles, California, 90095, United States|Universityof California, Irvine, Orange, California, 92868, United States|Saint John's Health Center - John Wayne Cancer Institute (JWCI), Santa Monica, California, 90404, United States|Stanford University School of Medicine, Stanford, California, 94304, United States|Hartford Health Care Cancer Institute, Hartford, Connecticut, 06102, United States|Eastern Connecticut Hematology & Oncology Associates (ECHO), Norwich, Connecticut, 06360, United States|Medstar Georgetown University Medical Center, Washington, District of Columbia, 20007, United States|Miami Cancer Institute, Baptist Health South Florida, Miami, Florida, 33176, United States|Northwestern University, Chicago, Chicago, Illinois, 60611, United States|Indiana University - Melvin and Bren Simon Cancer Center (IUSCC), Indianapolis, Indiana, 46202, United States|The University of Iowa and Holden Comprehensive Cancer Center, Iowa City, Iowa, 52242, United States|Norton Cancer Center, Louisville, Kentucky, 40207, United States|Ochsner Cancer Institute, New Orleans, Louisiana, 70121, United States|University of Maryland, Marlene and Stewart Greenebaum Cancer Center, Baltimore, Maryland, 21201, United States|University of Michigan, Ann Arbor, Michigan, 48109, United States|Minnesota Oncology Hematology P.A. (USO - US Oncology), Minneapolis, Minnesota, 55404, United States|Comprehensive Cancer Centers of Nevada (CCCN), Las Vegas, Nevada, 89169, United States|John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, 07601, United States|University of New Mexico UNM Cancer Research and Treatment Center, Albuquerque, New Mexico, 87102, United States|New York Oncology Hematology, P.C. (USO - US Oncology), Albany, New York, 12208, United States|Roswell Park Cancer Institute, Buffalo, New York, 14263, United States|New York - Presbyterian Hospital-Weill Cornell Medical Center, New York, New York, 10021, United States|Memorial Sloan Kettering Cancer Center, New York, New York, 10065, United States|Duke University, Duke Cancer Institute, Durham, North Carolina, 27710, United States|Stephenson Cancer Center, Oklahoma City, Oklahoma, 73104, United States|Northwest Cancer Specialists P.C. (USO - US Oncology), Portland, Oregon, 97062, United States|Providence Portland Medical Center, Portland, Oregon, 97213, United States|Oregon Health and Science University, Portland, Oregon, 97239, United States|Lehigh Valley Health Network, Allentown, Pennsylvania, 18103, United States|Penn State Hershey Medical Center, Hershey, Pennsylvania, 17033, United States|Atlantic Urology Clinics, Myrtle Beach, South Carolina, 29572, United States|University Oncology & Hematology, Chattanooga, Tennessee, 37403, United States|Urology Associates, Nashville, Tennessee, 37209, United States|Texas Oncology PA (USO - US Oncology), Dallas, Texas, 76201, United States|University of Texas, UT Health Science Center, Houston, Texas, 77030, United States|University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah, 84112, United States|University of Virginia, Emily Couric Clinical Center, Charlottesville, Virginia, 22908, United States|University of Washington / Seattle Cancer Care Alliance, Seattle, Washington, 98109, United States|Froedtert & Medical College of Wisconsin, Milwaukee, Wisconsin, 53226, United States|Centre de Lutte Contre le Cancer (CLCC) - Universite de Lyon - Centre Leon-Berard, Lyon, 69008, France|Hopital Saint-Louis, Paris, 75010, France|Centre de Lutte Contre le Cancer - Institut de Cancerologie de l'Ouest - Rene Gauducheau, Saint-Herblain, 44805, France|Institut Universitaire du Cancer de Toulouse - Oncopole, Toulouse, 31059, France|Institut Gustave Roussy, Villejuif, 94805, France|Urologische und Kinderurologische Universit?tsklinik im Malteser, Erlangen, 91054, Germany|Universitatsklinikum Munster / Urologie und Kinderurologie, Münster, 26133, Germany|Studienpraxis Urologie, Nurtingen, 72622, Germany|Fondazionerca sul Cancro ONLUS - Istituto di Candiolo IRCCS, Candiolo, 10060, Italy|IRCCS Ospedale San Raffaele - Medical Oncology Dept, Milano, 20132, Italy|Fondazione IRCCS Istituto Nazionale Tumori, Milano, 20133, Italy|Azienda Ospedaliera Universitaria Federico II Oncologia Medica, Naples, 80131, Italy|Universidad de Navarra - Clinica Universitaria de Navarra, Pamplona, Navarre, 31008, Spain|Hospital del Mar, Barcelona, 08003, Spain|Hospital Santa Creu i Sant Pau, Barcelona, 08025, Spain|Hospital Universitari Vall d'Hebron de Barcelona, Barcelona, 08035, Spain|Hospital General Universitario Gregorio Maranon, Madrid, 28007, Spain|Clinica Universitaria de Navarra Madrid, Madrid, 28027, Spain|MD Anderson Cancer Center, Madrid, 28033, Spain|Hospital Universitario 12 de Octubre, Madrid, 28041, Spain|Hospital Clínico Universitario de Santiago de Compostela, Santiago De Compostela, 15706, Spain|Sarah Cannon Research Institute - United Kingdom - London Office, London, CH63 4JY, United Kingdom|Guy's & St. Thomas' Hospital (London Oncology Clinic), London, W1G 6AF, United Kingdom Less <<
NCT04539327 Epithelial Ovarian Cancer|Fall... More >>opian Tube Cancer|Primary Peritoneal Cancer Less << COMPLETED 2021-07-31 Hospital Torrecárdenas, Almerí... More >>a, Andalucía, 04009, Spain|Hospital Universitario Virgen de la Victoria, Málaga, Andalucía, 29010, Spain|Hospital Universitario Virgen del Rocío, Sevilla, Andalucía, 41013, Spain|Hospital Universitario Nuestra Se?ora de Valme, Sevilla, Andalucía, 41014, Spain|Hospital General San Jorge, Huesca, Aragón, 22004, Spain|Hospital Clínico Universitario Lozano Blesa, Zaragoza, Aragón, 50009, Spain|Hospital Universitario Miguel Servet, Zaragoza, Aragón, 50009, Spain|Hospital del Mar, Barcelona, Catalunya, 08003, Spain|Hospital Clínic i Provincial, Barcelona, Catalunya, 08036, Spain|Instituto Valenciano De Oncologia, Valencia, Comunitat Valenciana, 46009, Spain|Hospital Universitari i Politecnic La Fe, Valencia, Comunitat Valenciana, 46026, Spain|Hospital Público Lluis Alcanyis, Xàtiva, Comunitat Valenciana, 46800, Spain|Complejo Hospitalario Universitario de Pontevedra, Pontevedra, Galicia, 36071, Spain|Hospital Universitario Son Espases, Palma De Mallorca, Islas Baleares, 07120, Spain|Hospital Universitario de Fuenlabrada, Fuenlabrada, Madrid, 28942, Spain|Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Madrid, 28702, Spain|Hospital Universitario de Araba Txagorritxu, Gasteiz / Vitoria, País Basco, 01009, Spain|Clínica Universidad de Navarra, Madrid, 28027, Spain|MD Anderson Cancer Center, Madrid, 28033, Spain|Hospital Clínico San Carlos, Madrid, 28040, Spain|Hospital Universitario Fundación Jiménez Díaz, Madrid, 28040, Spain|Hospital Universitario 12 Octubre, Madrid, 28041, Spain|Centro Integral Oncológico Clara Campal, Madrid, 28050, Spain Less <<
NCT04676334 Metastatic Castration-Resistan... More >>t Prostate Cancer|Ovarian Cancer|Epithelial Ovarian Cancer|Fallopian Tube Cancer|Peritoneal Cancer|Other Solid Tumor Less << PHASE3 COMPLETED 2023-03-08 London Regional Cancer Centre,... More >> London, Ontario, Canada|Institut De Recherche De L'Hospital D'Ottawa, Ottawa, Ontario, Canada|Princess Margaret Hospital - Toronto, Toronto, Ontario, Canada|Centre Hospitalier de L'Universite de Montreal (CHUM), Montréal, Quebec, Canada|CIUSSS de l'Estrie - CHUS, Sherbrooke, Quebec, Canada|Carmel Medical Center, Haifa, Israel|Meir Medical Center, Kfar Saba, Israel|Istituto per la Ricerca e la Cura del Cancro Istituto di Candiolo, Candiolo, Torino, Italy|Azienda Ospedaliero-Universitaria di Bologna - Policlinico S.Orsola-Malpighi, Bologna, Italy|Istituto Europeo di Oncologia, Milano, Italy|Istituto Nazionale per lo studio e la cura dei tumori "Fondazione Pascale" Oncologia Medica, Napoli, Italy|Fondazione Policlinico Universitario Agostino Gemelli, Roma, Italy|Bia?ostockie Centrum Onkologii im. Marii Sk?odowskiej-Curie, Bia?ystok, Podlaskie, Poland|Wojewódzki Szpital Specjalistyczny w Olsztynie, Olsztyn, Warminsko-Mazurskie, Poland|Republic Clinical Oncology Dispensary of the Ministry of Healthcare of Republic of Bashkortostan, Ufa, Bashkortosta, Russian Federation|State Healthcare Institution Oncologic Dispensary No. 2 - Health Department of Krasnodar Region, Sochi, Krasnodar, Russian Federation|Republican oncological dispensary of Republic of Mordovia, Saransk, Mordovia, Russian Federation|Arkhangelsk Clinical Oncological Dispensary, Arkhangel'sk, Primorskiy, Russian Federation|Pyatigorsk Oncological Dispensary, Pyatigorsk, Stavropol, Russian Federation|N.N. Blokhin Russian Cancer Research Center, Moscow, Russian Federation|Omsk Regional Clinical Oncologic Dispensary, Omsk, Russian Federation|Ryazan Regional Clinical Oncology Dispensary, Ryazan', Russian Federation|Almazov National Medical Research Centre, Saint Petersburg, Russian Federation|University College London Hospitals, London, England, United Kingdom|East and North Hertfordshire NHS Trust, Middlesex, England, United Kingdom Less <<
NCT02952534 Metastatic Castration Resistan... More >>t Prostate Cancer Less << PHASE2 COMPLETED 2021-07-27 University of Alabama at Birmi... More >>ngham, Birmingham, Alabama, 35294, United States|Mayo Clinc, Phoenix, Arizona, 85259, United States|Arizona Oncology Associates, Tucson, Arizona, 85704, United States|Alliance Research Centers, Laguna Hills, California, 92653, United States|VA Greater Los Angeles Healthcare System, Los Angeles, California, 90073, United States|University of Southern California, Los Angeles, California, 90211, United States|Stanford University, Palo Alto, California, 94305, United States|Sharp Memorial Hospital, San Diego, California, 92123, United States|Pacific Hematology Oncology Associates, San Francisco, California, 94115, United States|San Francisco VA Health Care System, San Francisco, California, 94143, United States|UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, 94158, United States|Redwood Regional Medical Group, Santa Rosa, California, 95406, United States|Kaiser Permanente Medical Center (Vallejo), Vallejo, California, 94589, United States|Rocky Mountain Cancer Centers, Aurora, Colorado, 80012, United States|Yale School of Medicine, New Haven, Connecticut, 06510, United States|4701 Ogletown Stanton Rd., Newark, Delaware, 19713, United States|Georgetown University Medical Center, Washington, District of Columbia, 20007, United States|Boca Raton Community Hospital, Inc., Boca Raton, Florida, 33486, United States|Florida Cancer Specialists, Fort Myers, Florida, 33980, United States|University of Florida Health Cancer Center, Orlando, Florida, 32806, United States|Moffitt Cancer Center, Tampa, Florida, 33612, United States|Atlanta Urological Group, Atlanta, Georgia, 30312, United States|University of Chicago Comprehensive Cancer Center, Chicago, Illinois, 60637, United States|Ochsner Medical Center, New Orleans, Louisiana, 70121, United States|University of Maryland Greenebaum Cancer Center, Baltimore, Maryland, 21201, United States|Walter Reed Hospital, Bethesda, Maryland, 48202, United States|Massachusetts General Hospital, Boston, Massachusetts, 02114, United States|VA Ann Arbor Healthcare System, Ann Arbor, Michigan, 48105, United States|Henry Ford Hospital, Detroit, Michigan, 48202, United States|Fairview Hospital, Edina, Minnesota, 55435, United States|Minnesota Oncology Hematology, P.A., Minneapolis, Minnesota, 55404, United States|Minnesota Veterans Research Institute, Minneapolis, Minnesota, 55417, United States|HCA Midwest Division - Kansas City, Kansas City, Missouri, 64132, United States|Alegent Health Bergan Mercy Hospital , GU Research Network, Omaha, Nebraska, 68130, United States|Nebraska Cancer Specialists, Omaha, Nebraska, 68130, United States|Comprehensive Cancer Centers of Nevada, Las Vegas, Nevada, 89119, United States|Premier Urology Associates dba/AdvanceMed Research, Lawrenceville, New Jersey, 08648, United States|Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, 08901, United States|Roswell Park, Buffalo, New York, 14263, United States|NYU Perlmutter Cancer Center, New York, New York, 10016, United States|Memorial Sloan Kettering CC, New York, New York, 10065, United States|Weill Cornell Medical College/NewYork-Presbyterian Hospital, New York, New York, 10065, United States|Premier Medical Group of the Hudson Valley PC, Poughkeepsie, New York, 12301, United States|University of Rochester, Rochester, New York, 14642, United States|SUNY Upstate Medical University, Syracuse, New York, 13210, United States|Carolina Urology Partners, Concord, North Carolina, 28025, United States|The Urology Group, Cincinnati, Ohio, 45212, United States|Kettering Cancer Center, Kettering, Ohio, 45429, United States|Clinical Research Solutions, Middleburg Heights, Ohio, 44130, United States|VA Portland Health Care System, Portland, Oregon, 97219, United States|Consultants in Medical Oncology Hematology, Horsham, Pennsylvania, 19044, United States|SCRI - Tennessee Oncology, Nashville, Tennessee, 37203, United States|Texas Oncology Medical City Dallas, Dallas, Texas, 75320, United States|UT Southwestern Medical Center, Dallas, Texas, 75390, United States|UT Health Science Center, Houston, Texas, 77030, United States|Texas Oncology - Tyler, Tyler, Texas, 75702, United States|Virginia Oncology Associates, Norfolk, Virginia, 23502, United States|VA Puget Sound, Seattle, Washington, 98108, United States|Northern Cancer Insitute, St. Leonards, Saint Leonards, New South Wales, 2065, Australia|Royal Hobart Hospital, Hobart, Tasmania, 7000, Australia|Peninsula & Southeast Oncology, Frankston, Victoria, 3199, Australia|Barwon Health, University Hospital Geelong, Geelong, Victoria, 3220, Australia|Cabrini Hospital, Malvern, Victoria, 3144, Australia|Southside Cancer Care Centre, Miranda, 2228, Australia|Orange Health Services, Orange, 2800, Australia|St John of God Hospital, Subiaco, Subiaco, 6008, Australia|Riverina Cancer Care Centre, Wagga Wagga, 2650, Australia|ZNA Middelheim, Antwerp, 2020, Belgium|Universitair Ziekenhuis Gent, Gent, B-9000, Belgium|AZ Groeninge, Kortrijk, 8500, Belgium|CHU Sart-Tilman, Liège, 4000, Belgium|Equipe de Recherche Clinique, Département d'Oncologie/Hématologie, Liège, 4000, Belgium|AZ DELTA, Roeselare, B-8800, Belgium|Juravinski Cancer Centre Hamilton Health Services, Hamilton, Ontario, L8V5C2, Canada|London Health Science Center - Victoria Hospital, London, Ontario, N6A 4L6, Canada|The Ottawa Hospital, Ottawa, Ontario, K1H8L6, Canada|Princess Margaret Hospital, Toronto, M5G 2M9, Canada|Copenhagen University Hospital, Copenhagen, 2100, Denmark|Herlev Hospital, Herlev, 2730, Denmark|Vejle Sygehus, Vejle, 7100, Denmark|Centre Fran?ois Baclesse, Caen, 14000, France|Centre Georges Fran?ois Leclerc, Dijon, 21079, France|Clinique Victor Hugo Centre Jean Bernard, Le Mans, 72000, France|H?pital Privé La Louvière, Lille, 59800, France|Polyclinique de Gentilly (Centre D'Oncologie De Gentilly), Nancy, 54100, France|Institut Curie, Paris, 75248, France|H?pital Privé des C?tes d'Armor, Plérin, 22190, France|CRLCC Eugene Marquis, Rennes, 35042, France|Gemeinschaftspraxis fur Hamatologie & Onkologie, Augsburg, 86150, Germany|Charite Universitatsmedizin Berlin, Berlin, 12200, Germany|Universitatsklinikum Carl Gustav Carus, Dresden, 01307, Germany|Universitatsklinikum Dusseldorf, Dusseldorf, 40225, Germany|Urologische Gemeinschaftspraxis, Emmendingen, 79312, Germany|Universitaetsklinikum Hamburg-Eppendorf (UKE), Hamburg, 20246, Germany|Universitaetsklinikum Heidelberg, Heidelberg, 69120, Germany|Universitatsklinikum Jena, Jena, 07747, Germany|Universit?tsklinik K?ln, K?ln, 50937, Germany|Universit?tsklinikum Schleswig-Holstein, Lübeck, 23538, Germany|Medizinischen Fakult?t Mannheim der Universit?t Heidelberg, Mannheim, 68167, Germany|Studienpraxis Urologie, Nürtingen, 72622, Germany|University of Tuebingen, Tuebingen, 72076, Germany|Die Gesundhehitsunion DGU, Wuppertal, 42103, Germany|Cork University Hospital, Cork, T12 DFK4, Ireland|St. Vincent's University Hospital, Dublin, D04T6F4, Ireland|St James's Hospital, Dublin, D08 NHY1, Ireland|Adelaide & Meath Hospital, Incorporating the National Children's Hospital, Dublin, Dublin 24, Ireland|Mater Misericordiae University Hospital, Dublin, Dublin 7, Ireland|Rambam Health Care Campus (RHCC), Rambam Medical Center, Haifa, 3109601, Israel|Hadassah University Hospital, Jerusalem, 71120, Israel|Meir Medical Center, Kfar Saba, 4428164, Israel|Rabin Medical Center-Beilinson Campus, Petach Tikva, 4941492, Israel|Chaim Sheba Medical Center, Ramat Gan, 52621, Israel|The Tel Aviv Sourasky Medical Center (Ichilov Hospital), Tel Aviv, 64231, Israel|Ospedale San Donato, Azienda USLSUDEST, Arezzo, 52100, Italy|Ospedale Santa Maria delle Croci, Faenza, 48018, Italy|IRCCS Istituto Nazionale dei Tumori (INT), Milano, 20133, Italy|IEO Instituto Europeo di Oncologia, Milano, 20141, Italy|University of Modena and Reggio Emilia Medical Oncology, Modena, 41124, Italy|Azienda Ospedaliera San Camillo-Forlanini, Rome, 00152, Italy|Azienda Opsedaliera S. Maria di Terni, Terni, 05100, Italy|Santa Chiara Hospital, Dept Medical Oncology, Trento, 38122, Italy|Hospital Universitari Germans Trias i Pujol, Badalona, 08916, Spain|Hospital del Mar, Servicio de Oncología, Barcelona, 08003, Spain|Hospital Clínic i Provincial de Barcelona-Oncology, Barcelona, 08036, Spain|Instituto Catalan de Oncologia, Barcelona, 08908, Spain|Hospital Universitari Germans Trias i Pujol, Barcelona, 08916, Spain|Hospital General Universitario de Guadalajara, Guadalajara, 19002, Spain|Hospital Universitario Lucus Augusti., Lugo, 27003, Spain|MD Anderson Cancer Center - Madrid, Madrid, 28033, Spain|Hospital Universitario Ramón y Cajal, Madrid, 28034, Spain|Hospital 12 de Octubre, Madrid, 28041, Spain|Hospital Universitario La Paz, Madrid, 28046, Spain|Hospital Puerta de Hierro-Majadahonda, Madrid, 28222, Spain|Hospital Universitario Central de Asturias, Oviedo, 33011, Spain|Corporacio Sanitaria Parc Tauli, Sabadell, 8208, Spain|Marques de Valdecilla University Hospital (HUMV), Santander, 39008, Spain|Hospital Universitario Virgen del Rocío, Sevilla, 41013, Spain|Instituto Valenciano de Oncologia IVO, Valencia, 46009, Spain|Wexham Park Hospital, Slough, Berkshire, SL2 4HL, United Kingdom|Mount Vernon Cancer Centre, Northwood, England, HA6 2RN, United Kingdom|Royal Marsden Hospital, Sutton, Surrey, SM2 5PT, United Kingdom|Oxford University Hospitals, Headington, OC3 7LJ, United Kingdom|Royal Liverpool Hospital, Liverpool, L7 8XP, United Kingdom|London Health Science Center - Victoria Hospital, London, N6A 4L6, United Kingdom|Guy's Hospital, London, SE1 9RT, United Kingdom|Sarah Cannon Research Institutute - UK, London, W1G 6AD, United Kingdom|Southampton General Hospital, Southampton, SO16 6YD, United Kingdom|Musgrove Park Hospital, Taunton, TA1 5DA, United Kingdom|The Clatterbridge Cancer Centre NHS Foundation Trust, Wirral, CH63 4JY, United Kingdom Less <<
NCT04171700 Solid Tumor PHASE2 TERMINATED 2022-07-15 UCLA Medicine Hematology and O... More >>ncology, Los Angeles, California, 90024, United States|UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, California, 94158, United States|Florida Cancer Specialists, Fort Myers, Florida, 33901, United States|Florida Cancer Specialists, Saint Petersburg, Florida, 33705, United States|H. Lee Moffitt Cancer Center & Research Institute, Tampa, Florida, 33612, United States|Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois, 60611, United States|University of Iowa Hospital and Clinics, Iowa City, Iowa, 52242, United States|Beth Israel Deaconess Medical Cancer Surgical Pavilion, Boston, Massachusetts, 02215, United States|Dana Farber Cancer Institute, Boston, Massachusetts, 02215, United States|New York Cancer And Blood Specialists, Bronx, New York, 10469, United States|Columbia University Irving Medical Center, New York, New York, 10032, United States|New York Cancer and Blood Specialists, Port Jefferson Station, New York, 11776, United States|Ohio State University, Columbus, Ohio, 43210, United States|Stephenson Cancer Center - The University of Oklahoma, Oklahoma City, Oklahoma, 73104, United States|University of Pennsylvania, Philadelphia, Pennsylvania, 19104, United States|UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, 15232, United States|SCRI/Tennessee Oncology - Chattanooga, Chattanooga, Tennessee, 37404, United States|Tennessee Oncology, Nashville, Tennessee, 37203, United States|Seattle Cancer Care Alliance/University of Washington, Seattle, Washington, 98109, United States Less <<
NCT03499444 Advanced Solid Tumor PHASE1 COMPLETED 2022-04-13 Division of Medical Oncology, ... More >>Hyogo Cancer Center, Akashi, Hyogo, 673-8558, Japan|Department of Gynecologic Oncology, Saitama Medical Univeristy international Medical Center, Hidaka, Saitama, 350-1298, Japan|Department of Breast and Medical Oncology, National Cancer Center Hospital, Tsukiji, Tokyo, 104-0045, Japan Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.09mL

0.62mL

0.31mL

15.46mL

3.09mL

1.55mL

30.93mL

6.19mL

3.09mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories